share_log

Merck & Co | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Merck & Co | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

默沙东 | FWP:自由书写募资说明书
美股SEC公告 ·  05/16 16:18

Moomoo AI 已提取核心信息

Merck & Co., through its subsidiary MSD Netherlands Capital B.V., has announced the pricing of a series of notes with varying interest rates and maturities. The notes, which are expected to be rated A1 by Moody's and A+ by S&P, will be issued in denominations of €850,000,000 each, with maturity dates ranging from 2032 to 2054 and annual coupons between 3.250% and 3.750%. The trade date is set for May 16, 2024, with a settlement date of May 30, 2024. The notes will be listed on the NYSE and governed by the laws of the State of New York. Joint Book-Running Managers for the offering include Citigroup Global Markets Europe AG, BNP Paribas, and Deutsche Bank Aktiengesellschaft, among others. The offering is SEC Registered and the notes will be redeemable before their respective maturity dates under certain conditions. The pricing term sheet is supplementary to the preliminary prospectus supplement issued by MSD Netherlands Capital B.V. on May 15, 2024.
Merck & Co., through its subsidiary MSD Netherlands Capital B.V., has announced the pricing of a series of notes with varying interest rates and maturities. The notes, which are expected to be rated A1 by Moody's and A+ by S&P, will be issued in denominations of €850,000,000 each, with maturity dates ranging from 2032 to 2054 and annual coupons between 3.250% and 3.750%. The trade date is set for May 16, 2024, with a settlement date of May 30, 2024. The notes will be listed on the NYSE and governed by the laws of the State of New York. Joint Book-Running Managers for the offering include Citigroup Global Markets Europe AG, BNP Paribas, and Deutsche Bank Aktiengesellschaft, among others. The offering is SEC Registered and the notes will be redeemable before their respective maturity dates under certain conditions. The pricing term sheet is supplementary to the preliminary prospectus supplement issued by MSD Netherlands Capital B.V. on May 15, 2024.
默沙东通过其子公司默沙东荷兰资本有限公司宣布了一系列利率和到期日各不相同的票据的定价。预计这些票据将被穆迪评为A1,标准普尔将评为A+,每张票据的面额为8.5亿欧元,到期日从2032年到2054年不等,年息率在3.250%至3.750%之间。交易日期定为2024年5月16日,结算日期为2024年5月30日。这些票据将在纽约证券交易所上市,受纽约州法律管辖。此次发行的联席账面管理人包括花旗集团环球市场欧洲股份公司、法国巴黎银行和德意志银行Aktiengesellschaft等。本次发行已在美国证券交易委员会注册,在某些条件下,票据将在各自的到期日之前兑换。定价条款表是默沙东荷兰资本有限公司于2024年5月15日发布的初步招股说明书补充文件的补充。
默沙东通过其子公司默沙东荷兰资本有限公司宣布了一系列利率和到期日各不相同的票据的定价。预计这些票据将被穆迪评为A1,标准普尔将评为A+,每张票据的面额为8.5亿欧元,到期日从2032年到2054年不等,年息率在3.250%至3.750%之间。交易日期定为2024年5月16日,结算日期为2024年5月30日。这些票据将在纽约证券交易所上市,受纽约州法律管辖。此次发行的联席账面管理人包括花旗集团环球市场欧洲股份公司、法国巴黎银行和德意志银行Aktiengesellschaft等。本次发行已在美国证券交易委员会注册,在某些条件下,票据将在各自的到期日之前兑换。定价条款表是默沙东荷兰资本有限公司于2024年5月15日发布的初步招股说明书补充文件的补充。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息